The inclusion of study characteristics as covariates in the meta‐analytic model, including participant age and disease status, exercise type, cancer type, cell line TP53 status, and serum incubation time, had a negligible influence on the magnitude of heterogeneity or the pooled treatment effect. The gene discussed is TP53; the disease is cancer.